share_log

United Imaging Healthcare Releases 2023 Annual Report, With Revenue Growth of 23.52%

United Imaging Healthcare Releases 2023 Annual Report, With Revenue Growth of 23.52%

联影医疗发布2023年年度报告,收入增长23.52%
PR Newswire ·  04/26 11:00

Along with the publication of its 2023 annual report and the Q1 2024 report, United Imaging Healthcare released its ESG report.

除了发布其2023年年度报告和2024年第一季度报告外,联合影像医疗还发布了其ESG报告。

SHANGHAI, April 27, 2024 /PRNewswire/ -- United Imaging Healthcare (SSE:688271), a global leader in manufacturing advanced medical imaging and radiotherapy equipment, has released their 2023 annual report. The report reveals that the company achieved 11.41 billion CNY in revenue in 2023, marking a stable increase of 23.52%. Net income attributable to the shareholders of the parent company was 1.97 billion CNY, reflecting a YoY increase of 19.21 %.

上海,2024年4月27日 /PRNewswire/ — 先进医学成像和放射治疗设备制造领域的全球领导者联合影像医疗保健(SSE: 688271)发布了2023年年度报告。报告显示,该公司在2023年实现了114.1亿元人民币的收入,稳定增长了23.52%。归属于母公司股东的净收益为19.7亿元人民币,同比增长19.21%。

The company also released its first quarter report for 2024. The report shows that in Q1 2024, United Imaging Healthcare recorded revenue of 2.35 billion CNY and net income attributable to the shareholders of 0.36 billion CNY, an increase of 6.22% and 10.20% respectively.

该公司还发布了2024年第一季度报告。报告显示,在2024年第一季度,联合影像医疗录得收入23.5亿元人民币,归属于股东的净收益为3.6亿元人民币,分别增长6.22%和10.20%。

In the past year, United Imaging Healthcare has adhered to their globalization strategy, expanding the sales network to cover major developed and emerging markets around the world. By the end of 2023, the company's global customer base had covered over 65 countries and regions. The company has obtained more than 700 product registration certificates or quality management system certifications, with 45 products receiving CE certification and 44 products passing FDA 510(k) registrations, allowing them to be commercially available in the US. In 2023, the company's overseas main business achieved YoY growth of over 54.72 %, reaching 1.68 billion CNY. Notably, sales of the company's high-end equipment experienced rapid growth.

在过去的一年中,United Imaging Healthcare坚持其全球化战略,将销售网络扩大到覆盖全球主要的发达和新兴市场。到 2023 年底,该公司的全球客户群已覆盖超过 65 个国家和地区。该公司已获得700多份产品注册证书或质量管理体系认证,其中45种产品获得了CE认证,44种产品通过了FDA 510(k)注册,从而可以在美国上市。2023年,该公司的海外主营业务实现了超过54.72%的同比增长,达到16.8亿元人民币。值得注意的是,该公司高端设备的销售快速增长。

The expanding market share is bolstered by the company's steadfast commitment to research and development (R&D) innovation. The report illustrates that United Imaging Healthcare has made substantial investments in enhancing its technology and solutions in 2023, totaling 1.92 billion CNY.

公司对研发(R&D)创新的坚定承诺推动了不断扩大的市场份额。该报告表明,联影医疗在2023年为增强其技术和解决方案进行了大量投资,总额为19.2亿元人民币。

In the past few years, United Imaging Healthcare has made new breakthroughs in collaborating with world-renowned universities and clinical and scientific research institutions such as Yale University and UC Davis, resulting in pioneering advancements like the advanced molecular imaging device for the brain. Complementing these collaborations, the company's commitment to healthcare accessibility is demonstrated by initiatives like partnering with GIC Prime in India and deploying a mobile PET/CT unit in Piacenza, Italy. These efforts underscore United Imaging Healthcare's dedication to "Equal Healthcare for All."

在过去的几年中,United Imaging Healthcare在与耶鲁大学和加州大学戴维斯分校等世界知名大学以及临床和科研机构合作方面取得了新的突破,取得了诸如先进的大脑分子成像设备之类的开创性进展。除了这些合作外,该公司对医疗保健可及性的承诺还体现在与印度GIC Prime合作以及在意大利皮亚琴察部署移动PET/CT设备等举措。这些努力凸显了联影医疗对 “人人享有平等的医疗保健” 的承诺。

To embrace sustainability, United Imaging Healthcare always adheres to the core values of "DEI," which is diversity, equity, and inclusivity," regards employees as the core driving force to promote sustainable development of the enterprise, and firmly protects the basic rights of employees.

为了拥抱可持续发展,United Imaging Healthcare始终坚持 “DEI” 的核心价值观,即多元化、公平和包容性,将员工视为促进企业可持续发展的核心动力,并坚定地保护员工的基本权利。

United Imaging Healthcare is committed to promoting a green enterprise and bolstering climate-related initiatives as a foundation for sustainable growth. The company's dedication is evident through continual enhancements to its environmental management system, adoption of eco-friendly and energy-efficient production methods, and vigilant monitoring of global climate shifts. As they pursue their own journey towards sustainability and strive for high-quality development, United Imaging Healthcare actively contributes to advancing ecological progress on a global scale.

United Imaging Healthcare致力于促进绿色企业和加强与气候相关的举措,以此作为可持续增长的基础。该公司的奉献精神通过持续改善其环境管理体系、采用环保和节能的生产方法以及警惕地监测全球气候变化,显而易见。在他们追求自己的可持续发展之旅并努力实现高质量发展的过程中,United Imaging Healthcare积极为推动全球生态进步做出贡献。

About United Imaging Healthcare

关于联合影像医疗保健

At United Imaging Healthcare, we develop and produce advanced medical products, digital healthcare solutions, and intelligent solutions that cover the entire process of imaging diagnosis and treatment.

在United Imaging Healthcare,我们开发和生产先进的医疗产品、数字医疗解决方案和智能解决方案,涵盖影像诊断和治疗的整个过程。

Founded in 2011, our company has subsidiaries and R&D centers across China, the United States, Poland, Dubai, and other parts of the world. With a cutting-edge digital portfolio and a mission of Equal Healthcare for All, we help drive industry progress and bold change.

我们公司成立于 2011 年,在中国、美国、波兰、迪拜和世界其他地区设有子公司和研发中心。凭借尖端的数字产品组合和 “人人享有平等医疗保健” 的使命,我们帮助推动行业进步和大胆变革。

To learn more, visit

要了解更多信息,请访问

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发